INTRODUCTION
Gastric cancer remains the second most common cancer diagnosed in the world. It accounts for 9.9% of all new cases of cancer diagnosed and is responsible for 12.1% of all cancer deaths [1] . Although the number of overall cancer deaths has declined, gastric cancer is still the leading cause of cancer death in Korea [2] . An essential step in managing gastric cancer is accurately assessing the preoperative stage and deciding on the adequate surgery including endoscopic treatment, minimal invasive surgery, and palliative operation.
However, managing gastric cancer is challenging because problems in determining treatment strategy remain as the prognosis has a wide range according to TNM classification [3] . There are limitations in the treatment of advanced gastric cancer (AGC) with surgery, whereas early gastric cancer (EGC) can be treated using minimal invasive surgery including endoscopy and laparoscopy with the limitation of lymphadenectomy [4, 5] . Traditionally, computed tomography (CT) has been used for preoperative staging of gastric cancer. CT provides useful in-formation on tumors based on anatomical structure, but there is a limitation in the accuracy of detection of EGC [6] .
It was reported that the diagnostic accuracy in T staging can be increased using multi-detector row CT (MDCT), but N staging which is one of the most important prognostic factor as deciding treatment strategy for EGC remain unsatisfactory [7, 8] .
Recently, Positron emission tomography (PET) using 18 F-fluorodeoxyglucose ( 
METHODS

Patients
MDCT technique
With Values are presented as number (%). PET/CT, positron emission tomography and computed tomography; LN, lymph node; LNM, lymph node metastasis; SRC, signet ring carcinoma.
a)
Papillary adenocarcinoma, well differentiated adenocarcinoma, moderately differentiated adenocarcinoma, poorly differentiated adenocarcinoma, and mucinous adenocarcinoma. 
F-FDG-PET/CT and MDCT image interpretation
An experienced gastrointestinal radiologist interpreted the MDCT images. Transverse and coronal MDCT images were evaluated with PACS monitors in random order. A lesion was determined to be cancerous when the gastric wall showed a focal thickening of at least 6 mm or greater or when focal enhancement was seen in the gastric wall.
Lymph nodes were considered metastatic if they were large than 8 mm in the short-axis diameter and oval [13] [14] [15] .
FDG uptake lesions of gastric wall and of lymph node bearing areas, regardless of size detected on PET/CT were regarded as malignancy, and the maximum standardized uptake value (SUVmax) was obtained using volume ROI. Values are presented as number/total number (%). 
Statistical analysis
We conducted Fisher's exact test for comparing the dif- 
RESULTS
Fifty one primary tumors were detected by pre- Table 1 ).
The correlation analysis showed a positive correlation exist between SUVmax of primary tumor and that of metastatic lymph node (P = 0.05, R = 0.43) (Fig. 1) . However, there was no significant correlation between SUVmax of primary tumor and tumor size.
When assessed using the Kruskall-Wallis test, the mean Values are presented as % (number/total number). PPV, positive predictive value; NPV, negative predictive value; PET/CT, positron emission tomography and computed tomography; LNM, lymph node metastasis; EGC, early gastric cancer; AGC, advanced gastric cancer. 27.0%, P = 0.039). However, there was no significant difference between the detection rate of 18 F-FDG-PET/CT (34/41 patients) and that of MDCT (37/41 patients) in AGC ( Table 2 ).
The SUVmax of primary tumor between EGC and AGC displayed similar result (6.0 ± 6.1, range 1.5 to 27.0 vs. 6.2 ± 2.9, range 2.2 to 13.2). However, the result of F-FDG-PET/CT was also superior to MDCT in terms of the specificity (86.7% vs. 75.6%, P = 0.029) ( Table 3) .
DISCUSSION
MDCT has also been widely used in the preoperative di- [17] . FDG-PET lacks accurate anatomical orientation when displaying metabolic information of malignancy [18] . The combination of PET and CT has emerged as the most accurate technology and provides good anatomical localization of functional data [19] . 18 F-FDG-PET/CT is increasingly used in the preoperative diagnosis of various cancers to determine staging, as well as in the detection of recurrence after curative surgery [9] . And recently, for the purpose of the detection of recurrence for gastric cancer after curative gastrectomy, 18 F-FDG-PET/CT has been introduced and shown comparable results to CT [20] . As shown in this study, the performance of (Fig. 2) .
In the present study, the detection rate of primary tumor and LNM in 53% [23, 24] . In one study, the detection rate of mucosal cancer was very low (16.7%) in comparison to that for submucosal cancer (68.8%) in MDCT [25] . In the present study, the detection rate of mucosal cancer and sub- FDG-PET has a low to moderate sensitivity of LNM due to its limited resolution; FDG-PET have a 4-to 5-mm resolution [27] , but 14.5% of metastatic lymph node in gastric cancer has the largest diameter of less than 3 mm [28] .
Another reason for the low sensitivity of FDG-PET is the masking of perigastric lymph node by the FDG uptake of the adjacent primary tumor.
18
F-FDG-PET/CT provides both anatomical and functional information and displays more accurate localization of both the primary tumor and lymph node with increased SUV than FDG-PET alone. We found that the sensitivity and specificity of 18 F-FDG-PET/CT in this study was comparable to a previous report in assessing lymph node status in gastric cancer (51.5%
and 86.7% vs. 54.7% and 92.2%) [29] .
The interesting finding from the present study was that both techniques had important informative role in preoperative staging of gastric cancer. In conclusion, 
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